Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep175 | Endocrine tumours and neoplasia | ECE2017

Follow-up in neuroendocrine tumors: is chromogranin A the confounder?

Martins Diana , Baptista Carla , Velez Ana , Macario Fernando , Carrilho Francisco

Introduction: Chromogranin A continues to be one of the most valuable markers for neuroendocrine tumors (NETs) however, it has several limitations, including its reduced specificity.Methods: The authors present the case of a patient diagnosed with a midgut NET, during follow-up.Results: Male patient, 61 years old, with chronic renal disease (CRD), underwent right hemicolectomy owing to ileo-cecal valve lesion; hist...